FDA approval for the first oral GLP-1 therapy for obesity the Wegovy (oral semaglutide 25 mg) pill
Altrient supplements are encapsulated in liposomes
GIP signalling has been implicated in both central and peripheral metabolic regulation, and may interact with reward pathways in ways that differ from or complement GLP-1 signalling
Thank you to our sponsors AG1 (Athletic Greens): Maui Nui: Thesis: WHOOP: InsideTracker: Supplements from Momentous Timestamps (00:00:00) Rick Rubin (00:04:08) Maui Nui Venison, Thesis, WHOOP, Momentous (00:08:23) Creativity & Ideas, Cloud Analogy (00:12:26) Language & Creativity
The titration timeline starting at 0.25 mg and increasing gradually over weeks is not a suggestion
[19] Afamelanotide (formerly the proprietary CUV1647) is currently being tested, in an implant delivery formulation, and clinically trialed by the Australian company Clinuvel Pharmaceuticals, for a series of conditions affecting the skin including erythropoietic protoporphyria (EPP), [20] polymorphous light eruption (PMLE), solar urticaria (SU), phototoxicity associated with systemic photodynamic therapy and actinic keratosis (AK) and squamous cell carcinoma skin cancer in patients who have received organ transplants, vitiligo and Hailey Hailey disease